BRTX vs LDOS · rev $401.0K vs P/E 16, rev $16.66B
BioRestorative Therapies Inc (BRTX) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
BRTX currently screens at market cap $10.2M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the BRTX and LDOS stock pages for the full models.
Not investment advice.